Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.
Method Article
This protocol allows one to identify factors that modulate functional beta cell mass to find potential therapeutic targets for the treatment of diabetes. The protocol consists of a streamlined method to assess islet replication and beta cell function in isolated rat islets following manipulation of gene expression with adenoviruses.
Glucose homeostasis is primarily controlled by the endocrine hormones insulin and glucagon, secreted from the pancreatic beta and alpha cells, respectively. Functional beta cell mass is determined by the anatomical beta cell mass as well as the ability of the beta cells to respond to a nutrient load. A loss of functional beta cell mass is central to both major forms of diabetes 1-3. Whereas the declining functional beta cell mass results from an autoimmune attack in type 1 diabetes, in type 2 diabetes, this decrement develops from both an inability of beta cells to secrete insulin appropriately and the destruction of beta cells from a cadre of mechanisms. Thus, efforts to restore functional beta cell mass are paramount to the better treatment of and potential cures for diabetes.
Efforts are underway to identify molecular pathways that can be exploited to stimulate the replication and enhance the function of beta cells. Ideally, therapeutic targets would improve both beta cell growth and function. Perhaps more important though is to identify whether a strategy that stimulates beta cell growth comes at the cost of impairing beta cell function (such as with some oncogenes) and vice versa.
By systematically suppressing or overexpressing the expression of target genes in isolated rat islets, one can identify potential therapeutic targets for increasing functional beta cell mass 4-6. Adenoviral vectors can be employed to efficiently overexpress or knockdown proteins in isolated rat islets 4,7-15. Here, we present a method to manipulate gene expression utilizing adenoviral transduction and assess islet replication and beta cell function in isolated rat islets (Figure 1). This method has been used previously to identify novel targets that modulate beta cell replication or function 5,6,8,9,16,17.
1. Adenoviral Transduction and Culturing of Rat Islets
[Note: From this point forward, please follow institutional protocols for the handling, use, and disposal of biohazardous materials.]
[Note: To verify adequate transduction efficiency, the use of a control virus expressing GFP is beneficial, as islets can then be imaged via confocal microscopy to verify penetration of the adenovirus into the islet core.]
[Note: From this point forward, please follow institutional protocols for the handling, use, and disposal of radioactive materials.]
2. Insulin Secretion Assay
[Note: As the islets are radioactive, please follow institutional protocols for the handling, use, and disposal of radioactive materials.]
[Note: Islets can be visualized using either a dissecting stereoscope or a standard microscope.]
[Note: As an alternative to settling by gravity, the tubes may be centrifuged at 300 x g for 1 min.]
3. Thymidine Incorporation Assay
4. Data Analysis
5. Representative Results
An example of the experiment to assess islet replication and beta cell function in rat islets is shown in Figure 2. This example shows that adenoviral overexpression of hypothetical "Gene #6" robustly stimulates islet replication without altering beta cell function. In the top panel, the results from the thymidine incorporation assay demonstrate that increasing the expression of "Gene #6" increases DNA synthesis, as measured by the incorporation of thymidine. Because most of the cells in the rat islet are beta cells, it is likely that this increase in thymidine incorporation indicates an increase in beta cell replication. However, confirmatory experiments must be performed to firmly establish this. In the bottom panel, the results from the insulin secretion assay demonstrate that overexpression of "Gene #6" did not alter one of the primary beta cell functions, i.e., insulin secretion at low and high glucose. The quality of the islet isolation and health of the islets following treatment with adenoviruses is indicated by the fold increase in insulin secretion at low and high glucose concentrations. If increasing the expression of "Gene #6" impaired beta cell function, this would likely be reflected as a decrease in the insulin secreted at high, stimulatory glucose concentrations (16.7 mM). A dose-response curve for varying glucose concentrations could also be performed.
Figure 1. Overview of protocol to assess islet replication and beta cell function in isolated rat islets following adenoviral-mediated alterations in gene expression. Freshly isolated rat islets are exposed to adenoviruses for 24 h and then cultured up to 96 h. Thymidine incorporation is assessed in the final 24 h, followed by the measurement of insulin secretion at low and high glucose.
Figure 2. Results from an experiment using a control adenovirus and an adenovirus overexpressing a hypothetical gene labeled as "Gene #6". The top panel shows the thymidine incorporation and the bottom panel the insulin secretion.
Establishing pathways that can be modulated to stimulate the replication and enhance the function of beta cells are relevant to both major forms of diabetes. Because functional beta cell mass is dependent on the existence and function of insulin-secreting cells, assessing these determinants simultaneously has its advantages. This protocol describes a streamlined protocol for identifying whether overexpression or suppression of a protein leads to changes in functional beta cell mass in vitro, which can the...
No conflicts of interest declared.
This work was supported by grant DK078732 from the NIH (to P.T.F).
Name | Company | Catalog Number | Comments |
RPMI 1640 media | Gibco | 11879 | |
Penicillin/streptomycin | Gibco | 15140 | |
6-well plate | BD-Falcon | 35-1146 | Non-TC treated |
[methyl-3H]-thymidine | Perkin Elmer | NET027Z001MC | 1 mCi/ml |
Micro-centrifuge tubes | Denville | C2170 | 1.7 ml |
NaCl | Sigma | 59888 | |
KCl | Acros | 42409 | |
KH2PO4 | Acros | 20592 | |
MgSO4 | Acros | 41348 | |
CaCl2 | Acros | 34961 | |
HEPES | Sigma | H0887 | 1 M solution |
35% BSA | Sigma | A7979 | |
NaHCO3 | Acros | 42427 | |
d-glucose | Sigma | G8769 | |
TCA | Fisher Scientific | SA9410-1 | 10% w/v |
NaOH | Acros | 12426 | |
Scintillation counting tube | Sarstedt | 58.536 | 7 ml, PP |
Scintillation counting tube cap | Sarstedt | 65.816 | |
Econo-Safe counting cocktail | RPI | 111175 | |
Insulin RIA | Siemens | TKIN2 | |
BCA Assay Kit | Thermo Scientific | 23250 | |
Equipment | |||
Centrifuge | Eppendorf | 5415R | |
Scintillation counting tube rack | Sarstedt | 93.1431.001 | |
Liquid scintillation counter | Perkin Elmer | Tri-Carb 2910TR |
Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE
Zapytaj o uprawnieniaThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone